These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3138530)

  • 1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
    Ishida T; In Y; Ohishi H; Yamamoto D; Inoue M; Tanaka C; Ueno Y; Ohmomo Y; Kanda N; Tanaka A
    Mol Pharmacol; 1988 Sep; 34(3):377-87. PubMed ID: 3138530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophor requirements of the aldose reductase inhibitor site.
    Kador PF; Sharpless NE
    Mol Pharmacol; 1983 Nov; 24(3):521-31. PubMed ID: 6415401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the nature of the charge transfer interaction at the aldose reductase inhibitor site.
    Kador PF; Nakayama T; Sato S; Smar M; Miller DD
    Prog Clin Biol Res; 1989; 290():237-50. PubMed ID: 2498900
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
    El-Kabbani O; Carbone V; Darmanin C; Oka M; Mitschler A; Podjarny A; Schulze-Briese C; Chung RP
    J Med Chem; 2005 Aug; 48(17):5536-42. PubMed ID: 16107153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible aldose reductase inhibitors.
    Kador PF; Gurley RC; Ares JJ; Miller DD
    Prog Clin Biol Res; 1987; 232():353-65. PubMed ID: 3112788
    [No Abstract]   [Full Text] [Related]  

  • 6. An artificial intelligence approach to the study of the structural moieties relevant to drug-receptor interactions in aldose reductase inhibitors.
    Klopman G; Buyukbingol E
    Mol Pharmacol; 1988 Dec; 34(6):852-62. PubMed ID: 3143909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of aldose reductases from rabbit lens by oxazole derivatives.
    Tanimoto T; Fukuda H; Kawamura J; Nakao M; Shimada U; Yamada A; Tanaka C
    Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1032-9. PubMed ID: 6430576
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aldose reductase inhibitors].
    Dostert P; Strolin Benedetti M
    J Pharmacol; 1986; 17(4):483-96. PubMed ID: 3104688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, activity, and molecular modeling of new 2, 4-dioxo-5-(naphthylmethylene)-3-thiazolidineacetic acids and 2-thioxo analogues as potent aldose reductase inhibitors.
    Fresneau P; Cussac M; Morand JM; Szymonski B; Tranqui D; Leclerc G
    J Med Chem; 1998 Nov; 41(24):4706-15. PubMed ID: 9822541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
    Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
    J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel, highly potent aldose reductase inhibitors: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4- tetrahydropyrrolo[1,2-a]pyrazine -4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (AS-3201) and its congeners.
    Negoro T; Murata M; Ueda S; Fujitani B; Ono Y; Kuromiya A; Komiya M; Suzuki K; Matsumoto J
    J Med Chem; 1998 Oct; 41(21):4118-29. PubMed ID: 9767647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
    Sotriffer CA; Krämer O; Klebe G
    Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and aldose reductase inhibitory activities of benzyl 2-oxazolecarbamate analogues.
    Miyahara N; Kasugai Y; Ohmomo Y; Tanaka C; Tanimoto T
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):245-8. PubMed ID: 1576679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro aldose reductase inhibitory activity of compounds containing an N-acylglycine moiety.
    DeRuiter J; Swearingen BE; Wandrekar V; Mayfield CA
    J Med Chem; 1989 May; 32(5):1033-8. PubMed ID: 2496229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors.
    Maccari R; Ottanà R; Curinga C; Vigorita MG; Rakowitz D; Steindl T; Langer T
    Bioorg Med Chem; 2005 Apr; 13(8):2809-23. PubMed ID: 15781392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spirohydantoin derivatives of thiopyrano[2,3-b]pyridin-4(4H)-one as potent in vitro and in vivo aldose reductase inhibitors.
    Da Settimo F; Primofiore G; La Motta C; Salerno S; Novellino E; Greco G; Lavecchia A; Laneri S; Boldrini E
    Bioorg Med Chem; 2005 Jan; 13(2):491-9. PubMed ID: 15598571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-pharmacophore analyses of aldose reductase inhibitory spiroquinazolinones.
    Nakao K; Asao M; Shirai H; Shimizu R
    Drug Des Discov; 1999 Aug; 16(2):155-63. PubMed ID: 10533811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase inhibition by anti-allergy drugs.
    Kador PF; Sharpless NE; Goosey JD
    Prog Clin Biol Res; 1982; 114():243-59. PubMed ID: 6131432
    [No Abstract]   [Full Text] [Related]  

  • 19. Protein structure-based de novo design and synthesis of aldose reductase inhibitors.
    Iwata Y; Naito S; Itai A; Miyamoto S
    Drug Des Discov; 2001; 17(4):349-59. PubMed ID: 11765138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotationally restricted mimics of rigid molecules: nonspirocyclic hydantoin aldose reductase inhibitors.
    Rizzi JP; Schnur RC; Hutson NJ; Kraus KG; Kelbaugh PR
    J Med Chem; 1989 Jun; 32(6):1208-13. PubMed ID: 2498517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.